Skip to main content
. 2017 Dec 19;8:282. doi: 10.1186/s13287-017-0726-8

Fig. 6.

Fig. 6

a Morphological features of hASCs exposed to SrRan. hASCs were treated with SrRan in GM and OM for 3 days. b hASCs exposed to SrRan in GM and OM, with cell viability measured with a CCK-8 assay. # p < 0.01 and * p < 0.05 compared with the control group